H.C. Wainwright reiterates Legend Biotech stock rating on durability data

🌐 Investing.com (Cyprus) —
H.C. Wainwright reiterates Legend Biotech stock rating on durability data

AI Summary

H.C. Wainwright reiterated its rating on Legend Biotech, citing data on the durability of treatment outcomes. The headline does not specify the rating or provide further details about the data.

Markets Health Legend Biotech H.C. Wainwright durability data biotechnology analyst rating

Read original source →